NEWS
New Feature!!!! University Subject Rankings in 12 branches
FOR SCIENTIST REGISTRATION FOR INSTITUTIONAL BULK REGISTRATION
FOR EDIT YOUR UNIVERSITY / INSTITUTION PAGE
Some differences of the AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
List without CERN, Statistical Data etc. Only in AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
AD
Scientific Index 2024
About Us
Methodology
Compare & Choose
Contact - FAQ
login
Login
person_add
Register
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
school
University Rankings
subject
University Subject Rankings
insights
Subject Rankings
place
Country Rankings
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
local_fire_department
Country Top Lists
John H Sampson
Duke University - Durham / United States
Medical and Health Sciences / Neurosurgery
AD Scientific Index ID: 1303262
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
John H Sampson's MOST POPULAR ARTICLES
1-)
Bevacizumab plus irinotecan in recurrent glioblastoma multiformeJJ Vredenburgh, A Desjardins, JE Herndon, J Marcello, DA Reardon, ...Journal of clinical oncology 25 (30), 4722-4729, 200716202007
2-)
Effect of nivolumab vs bevacizumab in patients with recurrent glioblastoma: the CheckMate 143 phase 3 randomized clinical trialDA Reardon, AA Brandes, A Omuro, P Mulholland, M Lim, A Wick, ...JAMA oncology 6 (7), 1003-1010, 20209342020
3-)
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trialM Weller, N Butowski, DD Tran, LD Recht, M Lim, H Hirte, L Ashby, ...The Lancet Oncology 18 (10), 1373-1385, 20179332017
4-)
Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastomaJH Sampson, AB Heimberger, GE Archer, KD Aldape, AH Friedman, ...Journal of clinical oncology 28 (31), 4722-4729, 20109072010
5-)
Phase II trial of gefitinib in recurrent glioblastomaJN Rich, DA Reardon, T Peery, JM Dowell, JA Quinn, KL Penne, ...Journal of Clinical Oncology 22 (1), 133-142, 20048732004
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept